Table 3. Multivariable analysis of the clinical features of oesophago-gastric cancer.
| Variable | Odds ratio (95% CI) |
|---|---|
|
Symptoms
| |
| Dysphagia | 139 (112–173) |
| Loss of weight | 8.9 (7.1–11.2) |
| Epigastric pain | 8.8 (7.0–11) |
| Dyspepsia | 6.0 (5.1–7.1) |
| Reflux | 5.7 (4.8–6.8) |
| Nausea or vomiting | 4.9 (4.0–6.0) |
| Abdominal pain | 2.6 (2.3–3.0) |
| Chest pain | 1.6 (1.4–1.9) |
| Constipation | 1.5 (1.2–1.7) |
|
Investigations
| |
| Thrombocytosis | 2.4 (2.0–2.9) |
| Low haemoglobin | 2.4 (2.1–2.7) |
| Low mean red cell volume | 5.2 (4.2–6.4) |
| Leucocytosis | 1.4 (1.2–1.7) |
| Raised inflammatory markers | 1.7 (1.4–2.0) |
| Abnormal hepatic enzymes | 1.3 (1.2–1.5) |
| Raised cholesterol | 0.8 (0.7–0.8) |
|
Interaction terms
| |
| Dysphagia and loss of weight | 0.2 (0.06–0.5) |
| Dysphagia and nausea or vomiting | 0.1 (0.06–0.2) |
Abbreviation: CI=confidence interval.